4//SEC Filing
Yarema Kristin 4
Accession 0001209191-21-034422
CIK 0001604464other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:29 PM ET
Size
5.2 KB
Accession
0001209191-21-034422
Insider Transaction Report
Form 4
Yarema Kristin
Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-05-18$14.55/sh−761$11,073→ 91,528 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted Restricted Stock Units.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 18, 2021 and May 19, 2021 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001803794
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:29 PM ET
- Size
- 5.2 KB